Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Managemen... (LIVIAN CRT-D enables physicians to provi...)

HOME >> BIOLOGY >> TECHNOLOGY

Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Management Business

Date:2/25/2008

LIVIAN CRT-D enables physicians to provide patients with individualized therapy using the following features:

-- SmartDelay(TM): quickly proposes programmable device settings, which

enables physicians to tailor individualized pacing therapies for their

patients

-- Bi-V Trigger with ventricular rate regulation: helps physicians manage

heart failure patients with frequent atrial arrhythmias

Upgraded LATITUDE Patient Management System The upgraded LATITUDE Patient Management system has enhanced remote monitoring capabilities that include:

-- A new alert in the CONFIENT ICD that notifies physicians if a

patient's percentage of right ventricular pacing increases above a

programmable threshold

-- A new alert in the LIVIAN CRT-D that notifies physicians if a

patient's percentage of biventricular pacing falls below a

programmable threshold

-- A programmable atrial arrhythmia burden alert in the CONFIENT ICD and

the LIVIAN CRT-D that enables physicians to detect and manage

arrhythmias. Patients with atrial fibrillation, particularly those

with heart failure, are at risk of stroke. By identifying arrhythmias

earlier, physicians can intervene with treatments to decrease this

risk.

Both the CONFIENT ICD and LIVIAN CRT-D enable physicians to manage their patients wirelessly on the LATITUDE Patient Management System. The LATITUDE system helps physicians impact patient outcomes by notifying them of changes in a patient's clinical status between normally scheduled follow-ups, enabling them to intervene earlier in a patient's care.

"These technologies are welcome improvements that are designed to provide earlier insight into changing patient conditions and enable me to devote time to patients who need me the most," said Brian Olshansky, M.D., Professor of Medicine, University of Iowa Hospit
'/>"/>

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents
2. Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007
3. Boston Scientific to Participate in Merrill Lynch Conference
4. CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium
5. Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
6. Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program
7. Boston Scientific Announces Results for Third Quarter Ended September 30, 2007
8. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
9. The 58th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Nov. 2-6
10. Boston Scientific Announces European Approval of Next-Generation Implantable Defibrillator
11. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board

Post Your Comments:

Boston Scientific Announces Three FDA Product Approvals for Its Cardiac Rhythm Managemen...(LIVIAN CRT-D enables physicians to provi...)